SCHEDULE: Lytton Reports Zero Ownership in scPharmaceuticals
Beneficial Ownership Report
Laurence W. Lytton has filed an amendment to Schedule 13G, reporting zero beneficial ownership of scPharmaceuticals Inc. common stock.
Summary
- Laurence W. Lytton filed an Amendment No. 2 to Schedule 13G concerning scPharmaceuticals Inc. common stock.
- The filing reports that Laurence W. Lytton beneficially owns 0 shares of scPharmaceuticals Inc. common stock.
- This represents 0% of the class of securities.
- The reporting person holds no sole or shared voting or dispositive power over the shares.
- The event requiring this filing occurred on September 30, 2025.
Sentiment
Score: 5
Explanation: This filing is a factual report of an individual's beneficial ownership, stating zero shares held. It does not contain information regarding the company's operational performance, financial health, or strategic direction, thus presenting a neutral sentiment regarding the company itself.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The reporting of zero beneficial ownership by Laurence W. Lytton, particularly as an amendment, could be interpreted by other shareholders as a complete divestment by this specific investor, potentially influencing market sentiment.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event which requires filing of this statement. |
| 11/14/2025 | Date of filing and signature by Laurence W. Lytton. |
Keywords
scPharmaceuticals, common stock, beneficial ownership, Schedule 13G, Lytton, SEC filing, ownership change
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.